Skip to main content

Table 2 Treatment characteristics for patients with limited stage small cell lung cancer (LS-SCLC) treated with chemoradiation, (n = 105)

From: The impact of quantitative CT-based tumor volumetric features on the outcomes of patients with limited stage small cell lung cancer

TreatmentN = 105 (%)
Induction chemotherapy85 (81%)
Concurrent chemoradiation92 (88%)
Radiation alone13 (12%)
Post-radiation chemotherapy53 (50%)
Any chemotherapy102 (97%)
Chemotherapy type
 Cisplatin/etoposide79
 Carboplatin/etoposide11
 Carboplatin/taxol1
 Cisplatin/irinotecan1
 Not available2
Median number of chemotherapy cycles (range)3 (2–7)
PCIa
 Yes63 (60%)
 No42 (40%)
Median RT dose received (range)45 (20–66.6)
 Daily52 (49%)
 BID51 (49%)
 Not available2 (2%)
  1. aPCI prophylactic cranial irradiation